Research & 6 Innovation 201 - ELRIG...Innovation TRENT VINEYARD, NOTTINGHAM 23rd March 2016 201 6...
1
BIOPHARMACEUTICALS: Room G2 Research & Innovation TRENT VINEYARD, NOTTINGHAM 23 rd March 2016 2016 #ELRIGRI16 www.elrig.org Biopharmaceutical drugs continue to increase market share and fill the pipeline of major drug companies. This trend, which is predicted to increase even further, results in a highly competitive commercial and scientific landscape. As such, any improvements to the drug discovery process will be able to yield significant benefits both in terms of cost of goods and, for the benefit of patients, bringing new drugs to market more quickly. Opening Remarks & Introduction of Keynote speaker 9:15 - 10:15 9:00 - 9:15 10:45 - 10:55 10:55 - 11:25 TIME POSTER TASTERS SNAPSHOT PRESENTATIONS LUNCH - EXHIBITION - POSTERS PLENARY KEYNOTE: ROOM F1 CLOSE OF CONFERENCE SPEAKER TITLE Mark Wigglesworth, AstraZeneca Mike Jowett, Illumina Overcoming Manufacturing Commercialisation Challenges for Cell and Gene Therapy Stephen Ward Cell Therapy Catapult Opening Remarks Session Chairs COFFEE BREAK (Exhibition & Posters) COFFEE BREAK (Exhibition & Posters) Chairs: Gary Pettman, MedImmune and David Krige, Immunocore Discovering Novel Antibody Targets by Phenotypic Screening Andrea Gonzalez-Munoz MedImmune Streamlining High-Throughput Flow Cytometry For the Drug Discovery Process Stephen Rapecki UCB, Slough Leveraging Smart Automation in the Biopharmaceutical Industry & the Dawn of Terrabyte Product Files Will Lewis GlaxoSmithKline Tailoring CHO Cell Metabolism via microRNA Manipulation Niall Barron Irish National Institute for Cellular Biotechnology (NICB) ImmTACs: Changing the Therapeutic Perspective Andy Johnson Immunocore Developing Tumor-Localized, Combination Immunotherapies by Arming the Oncolytic Group B Adenovirus Enadenotucirev Brian Champion PsiOxus Therapeutics Ltd Discovering and Developing Novel Anti-Cancer Biotherapeutics: The View From Cancer Research UK James Ritchie Cancer Research UK (CRUK) 11:25 - 11:55 12:25 - 12:55 11:55 - 12:25 12:55 - 14:00 14:00 - 14:30 14:30 - 15:00 15:30 - 16:00 15:00 - 15:30 16:00 - 16:30 16:30 - 17:00 17:00 - 17:30 10:15 - 10:45 Vicky Day, BMG Labtech Ltd Anna Groom, LabLogic Donna Potts, Agilent Steve Davenport, IntelliCYT
Transcript of Research & 6 Innovation 201 - ELRIG...Innovation TRENT VINEYARD, NOTTINGHAM 23rd March 2016 201 6...
BIOPHARMACEUTICALS: Room G2
Research &InnovationTRENT VINEYARD, NOTTINGHAM23rd March 2016
2016
#ELRIGRI16
www.elrig.org
Biopharmaceutical drugs continue to increase market share and fill the pipeline of major drug companies. This trend, which is predicted to increase even further, results in a highly competitive commercial and scientific landscape. As such, any improvements to the drug discovery process will be able to yield significant benefits both in terms of cost of goods and, for the benefit of patients, bringing new drugs to market more quickly.
Opening Remarks & Introduction of Keynote speaker
9:15 - 10:15
9:00 - 9:15
10:45 - 10:55
10:55 - 11:25
TIME
POSTER TASTERS
SNAPSHOT PRESENTATIONS
LUNCH - EXHIBITION - POSTERS
PLENARY KEYNOTE: ROOM F1
CLOSE OF CONFERENCE
SPEAKER TITLE
Mark Wigglesworth, AstraZenecaMike Jowett, Illumina
Overcoming Manufacturing Commercialisation Challenges for Cell and Gene TherapyStephen Ward
Cell Therapy Catapult
Opening RemarksSession Chairs
COFFEE BREAK (Exhibition & Posters)
COFFEE BREAK (Exhibition & Posters)
Chairs: Gary Pettman, MedImmune and David Krige, Immunocore
Discovering Novel Antibody Targets by Phenotypic Screening
Andrea Gonzalez-MunozMedImmune
Streamlining High-Throughput Flow Cytometry For the Drug Discovery Process
Stephen RapeckiUCB, Slough
Leveraging Smart Automation in the Biopharmaceutical Industry & the Dawn of Terrabyte Product Files
Will LewisGlaxoSmithKline
Tailoring CHO Cell Metabolism via microRNA Manipulation
Niall BarronIrish National Institute for Cellular Biotechnology (NICB)
ImmTACs: Changing the Therapeutic PerspectiveAndy JohnsonImmunocore
Developing Tumor-Localized, Combination Immunotherapies by Arming the Oncolytic Group B Adenovirus Enadenotucirev
Brian ChampionPsiOxus Therapeutics Ltd
Discovering and Developing Novel Anti-Cancer Biotherapeutics: The View From Cancer Research UK
James RitchieCancer Research UK (CRUK)
11:25 - 11:55
12:25 - 12:55
11:55 - 12:25
12:55 - 14:00
14:00 - 14:30
14:30 - 15:00
15:30 - 16:00
15:00 - 15:30
16:00 - 16:30
16:30 - 17:00
17:00 - 17:30
10:15 - 10:45
Vicky Day, BMG Labtech LtdAnna Groom, LabLogic
Donna Potts, AgilentSteve Davenport, IntelliCYT
![Syllabus for Managing Innovation and Product …Module 1: The Innovation Challenge [01] 10:05AM Thu, Sep 9, Hawes Hall 201 [02] 11:40AM Thu, Sep 9, Hawes Hall 201 TOPIC Innovation](https://static.fdocuments.us/doc/165x107/5ed530e5763f026d7774123d/syllabus-for-managing-innovation-and-product-module-1-the-innovation-challenge.jpg)
